Condition
Wheat Hypersensitivity
Total Trials
4
Recruiting
2
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 2 (1)
Trial Status
Recruiting2
Not Yet Recruiting1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07816432Phase 2Not Yet Recruiting
A Study to Evaluate the Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Characteristics of LP-003 Injection in Participants With Wheat Allergy
NCT06035328Not ApplicableRecruitingPrimary
Comparison Efficacy Between Two Different Frequency of Maintenance Dose Oral Immunotherapy
NCT06152445Not ApplicableRecruiting
Wheat Bread Study: Comparison of the Tolerance of Different Wheat Breads
NCT03288831Not ApplicableCompleted
Changes in Intestinal Permeability 4 Hours After Gluten Challenge
Showing all 4 trials